Episode #102: Hybrid Peptides, Peptide Research Updates, and Bioregulators
LONGEVITY with Nathalie Niddam
00:00
Yhe as Soeble, More as We Go, but Definitely, It's Worth a Try.
The next peptide we were going to talk about, which is on the agenda, was thymus and alpha one. This is a new version of thymasinapa that has very, very precise activity,. or affinity for tumer cells. Yhe as soeble, more as we go, but definitely, there's some great research around it. If you can, if you can talk your dock into writing you a prescription for it, it's definitely worth a try.
Play episode from 21:14
Transcript
